Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion type Assertion NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_head.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion description "[The data provide further evidence that targeted inhibition of MEK may be therapeutically effective for thyroid cancer, particularly if the PI3K and NF-kappaB pathways are concurrently inhibited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_provenance.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion evidence source_evidence_literature NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_provenance.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion SIO_000772 18651802 NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_provenance.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion wasDerivedFrom befree-20140225 NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_provenance.
- NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_assertion wasGeneratedBy ECO_0000203 NP322653.RACZ3mORdkKyd295qpbE03AJ9Y7XEXzbMbC1X-j4uIYTI130_provenance.